Focus: Infection Control

Rare E. coli found in Los Angeles County patient

Incident marks a first for California


A Los Angeles county resident was infected with a rare, drug-resistent E. coli bacteria, according to an article on the LA. Daily News website.

 

The incident marks a first for California and local public health officials issued an advisory.

 

“The appearance of mcr-1 in Los Angeles serves as a reminder of the importance of infection control measures and antibiotic stewardship,” a public health official said in an alert.

 

Last month, the health department mandated that CRE be reported by all acute care hospitals and skilled nursing facilities in Los Angeles County.

 

Read the article.

 

 



February 10, 2017


Topic Area: Infection Control


Recent Posts

Making Healthcare Lighting Retrofits Work

Effective operational planning determines whether a retrofit project improves a facility or creates new problems.


Stadium Design is Reshaping Healthcare Facilities

Hospitals are turning to the sports industry for innovative ways to support healing and improve the patient experience.


AHN Reveals Plans to Build New Canonsburg Hospital in Pennsylvania

Construction of the new facility is anticipated to start in early 2027, with an anticipated opening in 2029.


Designing for Distraction: Benefits for Children, Families

Designers who can incorporate distractions into pediatric healthcare facilities can help children and families successfully navigate healthcare journeys.


Staffing and Consolidation Reshape Outpatient Facility Strategies

Labor shortages and health system consolidation are driving new approaches to outpatient facility planning.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.